Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
SOLV
Solventum Corporation
V.A.C. Peel and Place dressing is a wound care device, a core MedSurg product.
|
$14.39B |
$81.69
-1.55%
|
|
BBIO
BridgeBio Pharma, Inc.
Attruby (acoramidis) and other BridgeBio pipeline assets are oral small-molecule therapeutics, covering multiple rare genetic diseases.
|
$14.24B |
$74.72
-0.57%
|
|
UHS
Universal Health Services, Inc.
UHS has a strong behavioral health care segment offering inpatient and outpatient behavioral health services.
|
$14.17B |
$224.11
+0.68%
|
|
FMS
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care manufactures and provides Blood Purification Devices used in dialysis, including the 5008X CAREsystem.
|
$13.85B |
$23.64
+0.17%
|
|
VTRS
Viatris Inc.
Viatris is a large-scale producer of generic medicines and biosimilars, core to its business.
|
$13.58B |
$11.65
+0.04%
|
|
NDSN
Nordson Corporation
Atrion's medical components and medical device technologies place Nordson in the medical devices & biometrics space.
|
$13.31B |
$237.29
+0.78%
|
|
UNM
Unum Group
Health Insurance products are part of Unum's workplace benefits and risk protections in the employee benefits mix.
|
$13.13B |
$77.14
+0.02%
|
|
SMMT
Summit Therapeutics Inc.
Ivonescimab is a PD-1/VEGF bispecific antibody, placing Summit in the Bispecific Antibodies investable theme.
|
$12.91B |
$17.41
-0.91%
|
|
OKLO
Oklo Inc.
Atomic Alchemy's production of high-value radioisotopes for medical, industrial, defense, and AI applications aligns with radiopharmaceuticals.
|
$12.90B |
$83.43
-4.56%
|
|
IONS
Ionis Pharmaceuticals, Inc.
Ionis's core platform is RNA-targeted antisense oligonucleotides, directly aligning with the Oligonucleotide Therapeutics category.
|
$12.88B |
$79.71
-1.37%
|
|
MDGL
Madrigal Pharmaceuticals, Inc.
Rezdiffra is an oral, small-molecule therapeutic (THR-β agonist) approved for MASH, directly matching the 'Oral Small Molecule Therapeutics' category.
|
$12.74B |
$553.12
-3.21%
|
|
GH
Guardant Health, Inc.
Core product category: Guardant Health's liquid biopsy tests (Guardant360 Liquid/Tissue) are the primary offerings.
|
$12.73B |
$102.97
+0.88%
|
|
ASND
Ascendis Pharma A/S
Ascendis Pharma focuses on rare-disease endocrinology therapies (YORVIPATH, SKYTROFA, TransCon CNP) within biotech, fitting the Biotech - Rare Diseases category.
|
$12.68B |
$213.50
-3.14%
|
|
TEM
Tempus AI, Inc.
Laboratory Testing & Advisory Services – Tempus provides outsourced laboratory testing and regulatory/advisory support.
|
$12.27B |
$69.36
-1.77%
|
|
PEN
Penumbra, Inc.
Penumbra's core offerings include vascular intervention devices used for thrombectomy and catheter-based clot removal.
|
$12.17B |
$310.48
-0.50%
|
|
ALGN
Align Technology, Inc.
Align's Invisalign system, iTero scanners, and direct 3D-printed dental devices are core dental equipment products.
|
$11.99B |
$163.87
-0.95%
|
|
GMED
Globus Medical, Inc.
Orthopedic devices and implants (spinal, ALIF spacers, knee systems) sold for reconstruction.
|
$11.71B |
$86.81
+0.13%
|
|
RDY
Dr. Reddy's Laboratories Limited
Significant emphasis on biosimilar development and commercialization.
|
$11.69B |
$14.04
+0.18%
|
|
RVTY
Revvity, Inc.
Revvity's Diagnostics segment includes diagnostic equipment and instruments.
|
$11.66B |
$98.67
-1.81%
|
|
DOC
Healthpeak Properties, Inc.
The CCRCs and healthcare facilities component places Healthpeak in Healthcare Services & Facilities.
|
$11.55B |
$16.62
+0.03%
|
|
MRNA
Moderna, Inc.
Direct vaccines products (Spikevax and pipeline vaccines) are Moderna's core revenue drivers and product line.
|
$11.46B |
$30.10
+2.17%
|
|
GL
Globe Life Inc.
Supplemental health/health insurance products marketed by Globe Life.
|
$11.30B |
$140.64
+0.85%
|
|
EXEL
Exelixis, Inc.
Exelixis is a biotech company focused on oncology therapies, including cabozantinib (CABOMETYX) and pipeline assets.
|
$11.00B |
$41.34
+1.11%
|
|
EHC
Encompass Health Corporation
Encompass Health operates inpatient rehabilitation hospital services, aligning with the Hospital Services investable theme.
|
$10.84B |
$107.47
+0.44%
|
|
ELAN
Elanco Animal Health Incorporated
Vaccines are a major product category and a focus of Elanco's innovation pipeline.
|
$10.78B |
$21.78
+2.30%
|
|
WBA
Walgreens Boots Alliance, Inc.
Home Health & Hospice – Through CareCentrix and related services, Walgreens provides home health coordination and related care services.
|
$10.36B |
$11.98
|
|
BMRN
BioMarin Pharmaceutical Inc.
BioMarin's core commercial therapies (VOXZOGO for skeletal disorders and enzyme replacement therapies like PALYNZIQ, VIMIZIM, NAGLAZYME) are all in the rare diseases space, fitting the Biotech - Rare Diseases investable theme.
|
$10.24B |
$51.96
-2.53%
|
|
QGEN
Qiagen N.V.
QIAGEN directly manufactures diagnostic instruments (e.g., QIAstat-Dx, QIAcuity, QIAsymphony Connect) and automated platforms.
|
$10.17B |
$45.22
-0.01%
|
|
JAZZ
Jazz Pharmaceuticals plc
Zanidatamab is a bispecific antibody, a core oncology modality represented by Bispecific Antibodies.
|
$10.16B |
$169.06
+0.93%
|
Showing page 5 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
